Oculis Publishes Consolidated Q2 Financial Statements and MD&A
ZUG, Switzerland, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Following the Company‘s press release published earlier today, the Q2 Consolidated Financial Statements and the MD&A, which have now been filed with the SEC on form 6-K, are attached.
Attachments


Upcoming Life Sciences Events
- March 2025
- Milan: BIO-Europe Spring® 2025
- April 2025
- Barcelona: RESI Europe 2025
- London: BioTrinity 2025